132 related articles for article (PubMed ID: 21342145)
1. Impact of chemoradiotherapy on vaginal and sexual function of patients with FIGO IIb cervical cancer.
Ljuca D; Marošević G
Bosn J Basic Med Sci; 2011 Feb; 11(1):62-4. PubMed ID: 21342145
[TBL] [Abstract][Full Text] [Related]
2. Impact of Treatment Time on Chemoradiotherapy in Locally Advanced Cervical Carcinoma.
Pathy S; Kumar L; Pandey RM; Upadhyay A; Roy S; Dadhwal V; Madan R; Chander S
Asian Pac J Cancer Prev; 2015; 16(12):5075-9. PubMed ID: 26163644
[TBL] [Abstract][Full Text] [Related]
3. Chemoradiation in cervical cancer with cisplatin and high-dose rate brachytherapy combined with external beam radiotherapy. Results of a phase-II study.
Strauss HG; Kuhnt T; Laban C; Puschmann D; Pigorsch S; Dunst J; Koelbl H; Haensgen G
Strahlenther Onkol; 2002 Jul; 178(7):378-85. PubMed ID: 12163992
[TBL] [Abstract][Full Text] [Related]
4. Patient-reported sexual adjustment after definitive chemoradiation and MR-guided brachytherapy for cervical cancer.
Conway JL; Gerber R; Han K; Jiang H; Xie J; Beiki-Ardakani A; Fyles A; Milosevic M; Williamson D; Croke J
Brachytherapy; 2019; 18(2):133-140. PubMed ID: 30509730
[TBL] [Abstract][Full Text] [Related]
5. Feasibility and acute toxicity of Concurrent Chemoradiotherapy (CCRT) with high-dose rate intracavitary brachytherapy (HDR-ICBT) and 40-mg/m2 weekly cisplatin for Japanese patients with cervical cancer: results of a Multi-Institutional Phase 2 Study (JGOG1066).
Toita T; Kitagawa R; Hamano T; Umayahara K; Hirashima Y; Aoki Y; Oguchi M; Mikami M; Takizawa K;
Int J Gynecol Cancer; 2012 Oct; 22(8):1420-6. PubMed ID: 22932262
[TBL] [Abstract][Full Text] [Related]
6. Manifestation pattern of early-late vaginal morbidity after definitive radiation (chemo)therapy and image-guided adaptive brachytherapy for locally advanced cervical cancer: an analysis from the EMBRACE study.
Kirchheiner K; Nout RA; Tanderup K; Lindegaard JC; Westerveld H; Haie-Meder C; Petrič P; Mahantshetty U; Dörr W; Pötter R
Int J Radiat Oncol Biol Phys; 2014 May; 89(1):88-95. PubMed ID: 24725693
[TBL] [Abstract][Full Text] [Related]
7. Dose-effect relationship and risk factors for vaginal stenosis after definitive radio(chemo)therapy with image-guided brachytherapy for locally advanced cervical cancer in the EMBRACE study.
Kirchheiner K; Nout RA; Lindegaard JC; Haie-Meder C; Mahantshetty U; Segedin B; Jürgenliemk-Schulz IM; Hoskin PJ; Rai B; Dörr W; Kirisits C; Bentzen SM; Pötter R; Tanderup K;
Radiother Oncol; 2016 Jan; 118(1):160-6. PubMed ID: 26780997
[TBL] [Abstract][Full Text] [Related]
8. Combined external and intracavitary irradiation in treatment of advanced cervical carcinomas: predictive factors for local tumor control and early recurrences.
Sorbe B; Bohr L; Karlsson L; Bermark B
Int J Oncol; 2010 Feb; 36(2):371-8. PubMed ID: 20043071
[TBL] [Abstract][Full Text] [Related]
9. Toxicity of concurrent chemoradiotherapy for locally advanced cervical cancer.
Jakubowicz J; Blecharz P; Skotnicki P; Reinfuss M; Walasek T; Luczynska E
Eur J Gynaecol Oncol; 2014; 35(4):393-9. PubMed ID: 25118480
[TBL] [Abstract][Full Text] [Related]
10. A Randomized Controlled Trial Comparing Clinical Outcomes and Toxicity of Lobaplatin- Versus Cisplatin-Based Concurrent Chemotherapy Plus Radiotherapy and High-Dose-Rate Brachytherapy for FIGO Stage II and III Cervical Cancer.
Wang JQ; Wang T; Shi F; Yang YY; Su J; Chai YL; Liu Z
Asian Pac J Cancer Prev; 2015; 16(14):5957-61. PubMed ID: 26320479
[TBL] [Abstract][Full Text] [Related]
11. Clinical Impact of Escalating Relative High-dose-rate Intracavitary Brachytherapy Dose in Stage IIB Cervical Cancer.
Cho O; Noh OK; Oh YT; Chang SJ; Chun M
Anticancer Res; 2017 Jan; 37(1):327-334. PubMed ID: 28011510
[TBL] [Abstract][Full Text] [Related]
12. Clinical outcomes of definitive chemoradiation followed by intracavitary pulsed-dose rate image-guided adaptive brachytherapy in locally advanced cervical cancer.
Castelnau-Marchand P; Chargari C; Maroun P; Dumas I; Del Campo ER; Cao K; Petit C; Martinetti F; Tafo-Guemnie A; Lefkopoulos D; Morice P; Haie-Meder C; Mazeron R
Gynecol Oncol; 2015 Nov; 139(2):288-94. PubMed ID: 26364808
[TBL] [Abstract][Full Text] [Related]
13. Topical estrogen, testosterone, and vaginal dilator in the prevention of vaginal stenosis after radiotherapy in women with cervical cancer: a randomized clinical trial.
Martins J; Vaz AF; Grion RC; Costa-Paiva L; Baccaro LF
BMC Cancer; 2021 Jun; 21(1):682. PubMed ID: 34112100
[TBL] [Abstract][Full Text] [Related]
14. [Occurrence of radiation-induced injury in vagina after radical radiotherapy of cervical cancer and its affecting factors].
Zhang KS; Liu Z; Wang T; Wang J; Su J; Shi F; Wang RH; Yuan W; Li Y
Zhonghua Fu Chan Ke Za Zhi; 2018 Apr; 53(4):257-262. PubMed ID: 29747271
[No Abstract] [Full Text] [Related]
15. Clinical outcome of protocol based image (MRI) guided adaptive brachytherapy combined with 3D conformal radiotherapy with or without chemotherapy in patients with locally advanced cervical cancer.
Pötter R; Georg P; Dimopoulos JC; Grimm M; Berger D; Nesvacil N; Georg D; Schmid MP; Reinthaller A; Sturdza A; Kirisits C
Radiother Oncol; 2011 Jul; 100(1):116-23. PubMed ID: 21821305
[TBL] [Abstract][Full Text] [Related]
16. Impact of Vaginal Symptoms and Hormonal Replacement Therapy on Sexual Outcomes After Definitive Chemoradiotherapy in Patients With Locally Advanced Cervical Cancer: Results from the EMBRACE-I Study.
Kirchheiner K; Smet S; Jürgenliemk-Schulz IM; Haie-Meder C; Chargari C; Lindegaard JC; Fokdal LU; Spampinato S; Schmid MP; Sturdza A; Mahantshetty U; Segedin B; Bruheim K; Rai B; Cooper R; Van der Steen-Banasik E; Wiebe E; Sundset M; van Limbergen E; Villafranca E; Westerveld H; Tan LT; Pötter R; Tanderup K; Nout RA;
Int J Radiat Oncol Biol Phys; 2022 Feb; 112(2):400-413. PubMed ID: 34478833
[TBL] [Abstract][Full Text] [Related]
17. Severe late toxicities following concomitant chemoradiotherapy compared to radiotherapy alone in cervical cancer: an inter-era analysis.
Gondi V; Bentzen SM; Sklenar KL; Dunn EF; Petereit DG; Tannehill SP; Straub M; Bradley KA
Int J Radiat Oncol Biol Phys; 2012 Nov; 84(4):973-82. PubMed ID: 22898381
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of nedaplatin-based concurrent chemoradiotherapy for FIGO Stage IB2-IVA cervical cancer and its clinical prognostic factors.
Fujiwara M; Isohashi F; Mabuchi S; Yoshioka Y; Seo Y; Suzuki O; Sumida I; Hayashi K; Kimura T; Ogawa K
J Radiat Res; 2015 Mar; 56(2):305-14. PubMed ID: 25428244
[TBL] [Abstract][Full Text] [Related]
19. High complete response rate of concomitant chemoradiotherapy for locally advanced squamous cell carcinoma of the uterine cervix.
Lin JC; Ho ES; Jan JS; Yang CH; Liu FS
Gynecol Oncol; 1996 Apr; 61(1):101-8. PubMed ID: 8626094
[TBL] [Abstract][Full Text] [Related]
20. Outcome and toxicity of radical radiotherapy or concurrent Chemoradiotherapy for elderly cervical cancer women.
Wang W; Hou X; Yan J; Shen J; Lian X; Sun S; Liu Z; Meng Q; Wang D; Zhao M; Qiu J; Hu K; Zhang F
BMC Cancer; 2017 Aug; 17(1):510. PubMed ID: 28764676
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
